KOE:060280
Curexo Inc. · KOE · Healthcare · KRW · FY for 2025
Figures on this page computed 2026-11-08 13:20 UTC
Last close
n/aKRW
Market data
97.0xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
- Computed from the filing for 2025
2.9%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
3.7%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
-18.4%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.01Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
Price is the furthest below its sector's middle: 0.19 against 0.36 on the market's range.
- Growth13.7%81 of 100, above its sector
- Returns on capital2.9%49 of 100, above its sector
- Margins29.6%42 of 100, above its sector
- Price97.0x19 of 100, below its sector
- Safety0.0193 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.55x
Its own average over 10 years, 48.18B.
- Profit-0.44x
Its own average over 10 years, -6.39B.
- Free cash flow1.35x
Its own average over 10 years, -10.17B.
- Debt0.43x
Its own average over 9 years, 2.72B.
- Pricen/a
Its own average over 0 years. Market data
Profit is furthest from its own average, at -0.44 times.
Sales is 1.55 times its own 10-year average; Profit is -0.44 times its own 10-year average; Free cash flow is 1.35 times its own 10-year average; Debt is 0.43 times its own 9-year average.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales against its own 10-year average1.55
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Profit against its own 10-year average-0.44
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Free cash flow against its own 10-year average1.35
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Debt against its own 9-year average0.43
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Price against its own 0-year averagen/aMarket data
Not held.
- Source
- market
- Reported in
- KRW